Cancer BiologyCell ReportsPeer-reviewed
Targeting Glioblastoma Signaling and Metabolism with A Re-Purposed Brain-Penetrant Drug
J. Bi, A. Khan, J. Tang…·P. S. Mischel
This study identifies fluoxetine as a potential therapy for glioblastoma by inhibiting SMPD1 and enhancing temozolomide efficacy, with real-world evidence suggesting improved survival.
DOI 10.1016/j.celrep.2021.109957